PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

UK researchers make new Alzheimer’s disease discovery

Researchers at the Universities of St Andrews and Edinburgh say they have discovered the functions of the area of the brain in which Alzheimer’s begins, potentially ...
Continue Reading →
News

CR UK research backs liquid biopsy for breast cancer

Cancer Research UK scientists are working on a new blood test able to identify rare mutations in advanced breast cancer, which could give patients quicker access to ...
Continue Reading →
News

ViiV submits dispersible form of dolutegravir in the US, EU

ViiV Healthcare has filed submissions in the US and EU for the first-ever dispersible formulation of dolutegravir (DTG) for children living with HIV. If approved, ...
Continue Reading →
News

New stem cell discovery could accelerate MND research

Two groups of scientists have identified a specific type of cell in the human body which can cause motor neurons to fail using stem cell technology. The discovery,...
Continue Reading →
News

Xtandi nabs FDA approval for certain prostate cancers

Pfizer and Astellas have announced that the US Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for the companies’ joint dr...
Continue Reading →
News

‘Smart needle’ could identify cancer instantly

A new “smart needle” has been developed by scientists to detect cancerous tissue using light. The researchers, funded by The National Institute for Health Research...
Continue Reading →
News

LEO’s experimental atopic dermatitis drug hits endpoints

LEO Pharma has announced that its experimental atopic dermatitis therapy, tralokinumab, has met all its primary and secondary endpoints in the ECZTRA 1, 2 and 3...
Continue Reading →
News

CR UK, Vaccitech strike deal for new immunotherapeutic vaccine

Cancer Research UK has announced a first-in-human trial to bring a novel immunotherapeutic vaccine strategy to patients with lung cancer. The treatment, which is p...
Continue Reading →
News

AZ’ Calquence boosts PFS in CLL patients

AstraZeneca’s Calquence has impressed in a Phase III trial assessing its impact on progression-free survival (PFS) in patients with chronic lymphocytic leukaemia (CL...
Continue Reading →
News

Sanofi bulks up cancer offering with Synthorx buy

Sanofi has announced its intention to buy Synthorx in a bid to beef up its immuno-oncology offering. The French drugs giant said it will pay $68 per share in cash ...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026